Genes and Pathways Co-associated with the Exposure to Multiple Drugs of Abuse, Including Alcohol, Amphetamine/Methamphetamine, Cocaine, Marijuana, Morphine, and/or Nicotine: a Review of Proteomics Analyses

Drug addiction is a chronic neuronal disease. In recent years, proteomics technology has been widely used to assess the protein expression in the brain tissues of both animals and humans exposed to addictive drugs. Through this approach, a large number of proteins potentially involved in the etiology of drug addictions have been identified, which provide a valuable resource to study protein function, biochemical pathways, and networks related to the molecular mechanisms underlying drug dependence. In this article, we summarize the recent application of proteomics to profiling protein expression patterns in animal or human brain tissues after the administration of alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine/heroin/butorphanol, or nicotine. From available reports, we compiled a list of 497 proteins associated with exposure to one or more addictive drugs, with 160 being related to exposure to at least two abused drugs. A number of biochemical pathways and biological processes appear to be enriched among these proteins, including synaptic transmission and signaling pathways related to neuronal functions. The data included in this work provide a summary and extension of the proteomics studies on drug addiction. Furthermore, the proteins and biological processes highlighted here may provide valuable insight into the cellular activities and biological processes in neurons in the development of drug addiction.

[1]  J. Hancock,et al.  H-Ras Signaling and K-Ras Signaling Are Differentially Dependent on Endocytosis , 2002, Molecular and Cellular Biology.

[2]  Dan J Stein,et al.  Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment , 2009, Metabolic Brain Disease.

[3]  M. Levin,et al.  Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. , 2005, Brain research. Molecular brain research.

[4]  B. Monsarrat,et al.  Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysis , 2006, Proteome Science.

[5]  D. Patterson,et al.  Localization of the L-glutamine synthetase gene to chromosome 1q23. , 1996, Genomics.

[6]  F Benfenati,et al.  Synaptic vesicle phosphoproteins and regulation of synaptic function. , 1993, Science.

[7]  C. Dlugos,et al.  Effects of chronic ethanol administration on brain protein levels: a proteomic investigation using 2-D DIGE system. , 2006, European journal of pharmacology.

[8]  Melinda E. Lull,et al.  Correlating Human and Animal Studies of Cocaine Abuse and Gene Expression , 2008, Annals of the New York Academy of Sciences.

[9]  L. Prokai,et al.  Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: a quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. , 2005, Journal of mass spectrometry : JMS.

[10]  T. Südhof,et al.  Differential expression and regulation of multiple dynamins. , 1994, The Journal of biological chemistry.

[11]  J. Silberring,et al.  Rat brain proteome in morphine dependence , 2006, Neurochemistry International.

[12]  M. Levin,et al.  Proteomic analysis of phosphotyrosyl proteins in the rat brain: Effect of butorphanol dependence , 2004, Journal of neuroscience research.

[13]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[14]  L. Huber.  Is proteomics heading in the wrong direction? , 2003, Nature Reviews Molecular Cell Biology.

[15]  M. Ehlers,et al.  Mechanisms and Function of Dendritic Exocytosis , 2011, Neuron.

[16]  Y. Yook,et al.  PRECLINICAL STUDY: Proteomic analysis of methamphetamine‐induced reinforcement processes within the mesolimbic dopamine system , 2008, Addiction biology.

[17]  H. Hermeking,et al.  14-3-3 proteins in cell cycle regulation. , 2006, Seminars in cancer biology.

[18]  I. McGregor,et al.  Protein expression profile in the striatum of rats with methamphetamine‐induced behavioral sensitization , 2007, Proteomics.

[19]  J. Reynolds,et al.  Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA) , 2006, Brain Research.

[20]  Ming D. Li,et al.  Nicotine modulates expression of dynamin 1 in rat brain and SH-SY5Y cells , 2011, Neuroscience Letters.

[21]  E. Nestler.  Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.

[22]  Z. Sun,et al.  Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. , 2007, Journal of proteome research.

[23]  Huibert D Mansvelder,et al.  Extracellular Matrix Plasticity and GABAergic Inhibition of Prefrontal Cortex Pyramidal Cells Facilitates Relapse to Heroin Seeking , 2010, Neuropsychopharmacology.

[24]  I. Matsumoto.  Proteomics approach in the study of the pathophysiology of alcohol-related brain damage. , 2009, Alcohol and alcoholism.

[25]  J Pohl,et al.  Distinct proteomic profiles of amphetamine self-administration transitional states , 2005, The Pharmacogenomics Journal.

[26]  David R. Willé,et al.  Serum proteomic analysis during nicotine self‐administration, extinction and relapse in rats , 2008, Electrophoresis.

[27]  M. Kashem,et al.  Differential protein expression in the corpus callosum (body) of human alcoholic brain , 2009, Journal of neurochemistry.

[28]  D. K. Berg,et al.  Rapid Activity-Driven SNARE-Dependent Trafficking of Nicotinic Receptors on Somatic Spines , 2005, The Journal of Neuroscience.

[29]  Melinda E. Lull,et al.  The use of neuroproteomics in drug abuse research. , 2010, Drug and alcohol dependence.

[30]  E. Domenici,et al.  Proteomic changes in rat serum, polymorphonuclear and mononuclear leukocytes after chronic nicotine administration , 2005, Proteomics.

[31]  Anna Larsson,et al.  Neurochemical and behavioral studies on ethanol and nicotine interactions , 2004, Neuroscience & Biobehavioral Reviews.

[32]  Eric R Kandel,et al.  Restricted and Regulated Overexpression Reveals Calcineurin as a Key Component in the Transition from Short-Term to Long-Term Memory , 1998, Cell.

[33]  J. Reynolds,et al.  Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes , 2008, Brain Research.

[34]  E. Nestler,et al.  Chromatin regulation in drug addiction and depression , 2009, Dialogues in clinical neuroscience.

[35]  Firas H Kobeissy,et al.  Psychoproteomic analysis of rat cortex following acute methamphetamine exposure. , 2008, Journal of proteome research.

[36]  W. Mcbride,et al.  Protein expression changes in the nucleus accumbens and amygdala of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol. , 2006, Alcohol.

[37]  Ming D. Li,et al.  Neuroproteomics and its applications in research on nicotine and other drugs of abuse , 2007, Proteomics. Clinical applications.

[38]  E. Martegani,et al.  Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol , 2009, Journal of Molecular Neuroscience.

[39]  Ming D. Li,et al.  Proteins differentially expressed in response to nicotine in five rat brain regions: Identification using a 2‐DE/MS‐based proteomics approach , 2006, Proteomics.

[40]  J. Morrison,et al.  The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens , 2010, Trends in Neurosciences.

[41]  E. Nestler.  Molecular mechanisms of drug addiction [published erratum appears in J Neurosci 1992 Aug;12(8):following table of contents] , 1992, Neuropharmacology.

[42]  Ming D. Li,et al.  Nicotine modulates expression of miR-140*, which targets the 3'-untranslated region of dynamin 1 gene (Dnm1). , 2009, The international journal of neuropsychopharmacology.

[43]  Ming D. Li,et al.  Common and Unique Biological Pathways Associated with Smoking Initiation/Progression, Nicotine Dependence, and Smoking Cessation , 2010, Neuropsychopharmacology.

[44]  R. Harris,et al.  The Application of Proteomics to the Human Alcoholic Brain , 2003, Annals of the New York Academy of Sciences.

[45]  X. Pu,et al.  Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia. , 2009, European journal of pharmacology.

[46]  Reinhard Jahn,et al.  SNAREs — engines for membrane fusion , 2006, Nature Reviews Molecular Cell Biology.

[47]  R. Lukas,et al.  Chaperone protein 14‐3‐3 and protein kinase A increase the relative abundance of low agonist sensitivity human α4β2 nicotinic acetylcholine receptors in Xenopus oocytes , 2006 .

[48]  F. Bossa,et al.  Primary structure and tissue distribution of human 4-aminobutyrate aminotransferase. , 1995, European journal of biochemistry.

[49]  C. Harper,et al.  Cerebellar vermis proteome of chronic alcoholic individuals. , 2007, Alcoholism, clinical and experimental research.

[50]  L. Brodin,et al.  Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. , 1997, Science.

[51]  M. von Zastrow,et al.  Dissociation of Functional Roles of Dynamin in Receptor-mediated Endocytosis and Mitogenic Signal Transduction* , 1999, The Journal of Biological Chemistry.

[52]  Gemma Navarro,et al.  Adenosine–cannabinoid receptor interactions. Implications for striatal function , 2010, British journal of pharmacology.

[53]  S. Das,et al.  Consequences of alcohol consumption on neurotransmitters -an overview. , 2008, Current neurovascular research.

[54]  Dieter Langosch,et al.  Functions of SNAREs in intracellular membrane fusion and lipid bilayer mixing , 2005, Journal of Cell Science.

[55]  S. Hemby.  Assessment of genome and proteome profiles in cocaine abuse. , 2006, Progress in brain research.

[56]  M. Ehlers,et al.  Organelles and trafficking machinery for postsynaptic plasticity. , 2006, Annual review of neuroscience.

[57]  S. Ho,et al.  Proteomic analysis of spinal protein expression in rats exposed to repeated intrathecal morphine injection , 2007, Proteomics.

[58]  S. Cordwell,et al.  A proteome analysis of the dorsolateral prefrontal cortex in human alcoholic patients , 2007, Proteomics. Clinical applications.

[59]  Y. Mechref,et al.  Differential expression of proteins in fetal brains of alcohol‐treated prenatally C57BL/6 mice: A proteomic investigation , 2010, Electrophoresis.

[60]  D. Mash,et al.  Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims , 2007, Molecular Psychiatry.

[61]  Philip R. Gafken,et al.  Proteomic analysis of native metabotropic glutamate receptor 5 protein complexes reveals novel molecular constituents , 2004, Journal of neurochemistry.

[62]  I. McGregor,et al.  Proteomic analysis demonstrates adolescent vulnerability to lasting hippocampal changes following chronic alcohol consumption. , 2009, Alcoholism, clinical and experimental research.

[63]  J. Mill,et al.  Drugs and addiction: an introduction to epigenetics. , 2011, Addiction.

[64]  Eric R. Kandel,et al.  Inducible and Reversible Enhancement of Learning, Memory, and Long-Term Potentiation by Genetic Inhibition of Calcineurin , 2001, Cell.

[65]  R. Scheller,et al.  Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. , 1992, Science.

[66]  P. De Camilli,et al.  The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamin , 1996, The Journal of cell biology.

[67]  S. Hemby.  Cocainomics: New Insights into the Molecular Basis of Cocaine Addiction , 2010, Journal of Neuroimmune Pharmacology.

[68]  J. Silberring,et al.  Morphinome – proteome of the nervous system after morphine treatment , 2005, Amino Acids.

[69]  M. Potenza,et al.  Neuroscience of Behavioral and Pharmacological Treatments for Addictions , 2011, Neuron.

[70]  N. Abul-Husn,et al.  Morphine Administration Alters the Profile of Hippocampal Postsynaptic Density-associated Proteins , 2007, Molecular & Cellular Proteomics.

[71]  A. Miralles,et al.  Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[72]  I. McGregor,et al.  Adolescent Rats Find Repeated Δ9-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure , 2008, Neuropsychopharmacology.

[73]  M. Cousin,et al.  The molecular physiology of activity‐dependent bulk endocytosis of synaptic vesicles , 2009, Journal of neurochemistry.

[74]  R. Malenka,et al.  Synaptic plasticity and addiction , 2007, Nature Reviews Neuroscience.

[75]  F. Witzmann,et al.  Proteomics and alcoholism. , 2004, International review of neurobiology.

[76]  R. Scheller,et al.  n-Sec1: a neural-specific syntaxin-binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Felix E Schweizer,et al.  The synaptic vesicle: cycle of exocytosis and endocytosis , 2006, Current Opinion in Neurobiology.

[78]  J. Bonifacino,et al.  The Mechanisms of Vesicle Budding and Fusion , 2004, Cell.

[79]  Fengqin Gao,et al.  Nicotine Induces Multi-site Phosphorylation of Bad in Association with Suppression of Apoptosis* , 2004, Journal of Biological Chemistry.

[80]  B. Walczak,et al.  Proteomic analysis of striatal neuronal cell cultures after morphine administration. , 2009, Journal of separation science.

[81]  J. Seong,et al.  A simple pattern classification method for alcohol‐responsive proteins that are differentially expressed in mouse brain , 2004, Proteomics.

[82]  E. Nestler,et al.  Molecular basis of long-term plasticity underlying addiction , 2001, Nature Reviews Neuroscience.

[83]  E. Nestler.  Molecular mechanisms of opiate and cocaine addiction , 1997, Current Opinion in Neurobiology.

[84]  G. Lubec,et al.  Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. , 2006, International journal of molecular medicine.

[85]  I. McGregor,et al.  Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization , 2008, Neuroscience Letters.

[86]  I. Shim,et al.  Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. , 2005, Biochemical and biophysical research communications.

[87]  J. Changeux,et al.  Nicotine addiction and nicotinic receptors: lessons from genetically modified mice , 2010, Nature Reviews Neuroscience.

[88]  N. Benowitz.  Pharmacology of nicotine: addiction and therapeutics. , 1996, Annual review of pharmacology and toxicology.

[89]  Gert Lubec,et al.  Limitations of current proteomics technologies. , 2005, Journal of chromatography. A.

[90]  Pingming Qiu,et al.  Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain , 2008, Neurochemistry International.

[91]  Jerzy Silberring,et al.  Morphinome – A meta‐analysis applied to proteomics studies in morphine dependence , 2011, Proteomics.

[92]  C. Harper,et al.  Differential protein expression in the prefrontal white matter of human alcoholics: a proteomics study , 2006, Molecular Psychiatry.

[93]  K. Xia,et al.  Interaction of the protein kinase Raf-1 with 14-3-3 proteins. , 1994, Science.

[94]  M. Kashem,et al.  Differential protein expression in the corpus callosum (genu) of human alcoholics , 2008, Neurochemistry International.

[95]  L. F. Alguacil,et al.  Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction , 2009, Neuropharmacology.

[96]  S. Hemby,et al.  Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration , 2010, Molecular Psychiatry.

[97]  I. McGregor,et al.  Protein expression profile in the striatum of acute methamphetamine-treated rats , 2006, Brain Research.

[98]  J. Mallet,et al.  Characterization of a presynaptic glutamate receptor. , 1993, Science.

[99]  R. Malenka,et al.  Involvement of a calcineurin/ inhibitor-1 phosphatase cascade in hippocampal long-term depression , 1994, Nature.

[100]  I. Verlaan,et al.  Dynamin Is Required for the Activation of Mitogen-activated Protein (MAP) Kinase by MAP Kinase Kinase* , 1999, The Journal of Biological Chemistry.

[101]  Daniel E Weeks,et al.  Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. , 2005, American journal of human genetics.

[102]  J. Churchich,et al.  Screening and sequence determination of a cDNA encoding the human brain 4-aminobutyrate aminotransferase. , 1995, Gene.

[103]  R. Malenka,et al.  Drug-Evoked Synaptic Plasticity in Addiction: From Molecular Changes to Circuit Remodeling , 2011, Neuron.

[104]  K. Befort,et al.  Mu opioid receptor: a gateway to drug addiction , 2004, Current Opinion in Neurobiology.

[105]  T. Rubino,et al.  The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex , 2009, Neurotoxicity Research.

[106]  W. Freeman,et al.  Proteomics for Protein Expression Profiling in Neuroscience , 2004, Neurochemical Research.

[107]  A. Smit,et al.  Intermittent administration of morphine alters protein expression in rat nucleus accumbens , 2006, Proteomics.

[108]  M. Daszykowski,et al.  The proteomic analysis of primary cortical astrocyte cell culture after morphine administration. , 2009, Journal of proteome research.

[109]  Kelly R. Tan,et al.  Hooked on benzodiazepines: GABAA receptor subtypes and addiction , 2011, Trends in Neurosciences.

[110]  M. Kashem,et al.  Differential protein expression in the corpus callosum (splenium) of human alcoholics: A proteomics study , 2007, Neurochemistry International.

[111]  T. Rudel,et al.  Ras-Raf Signaling Needs Prohibitin , 2005, Cell cycle.

[112]  M. Kashem,et al.  Differential protein expression profiles in the hippocampus of human alcoholics , 2007, Neurochemistry International.

[113]  J. Smiley,et al.  Microarray Analysis of Gene Expression in Rat Hippocampus After Chronic Ethanol Treatment , 2002, Neurochemical Research.

[114]  T. Südhof,et al.  Phosphorylation of dynamin I and synaptic-vesicle recycling , 1994, Trends in Neurosciences.

[115]  B. Tang,et al.  SNAREs in neurons – beyond synaptic vesicle exocytosis (Review) , 2006, Molecular membrane biology.

[116]  L. Lin,et al.  The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunit. Evidence for a dynamic role in subunit stabilization. , 2001, The Journal of biological chemistry.

[117]  Jinsam You,et al.  Differential effects of ethanol in the nucleus accumbens shell of alcohol-preferring (P), alcohol-non-preferring (NP) and Wistar rats: A proteomics study , 2009, Pharmacology Biochemistry and Behavior.

[118]  Ting-kai Li,et al.  Innate differences in protein expression in the nucleus accumbens and hippocampus of inbred alcohol‐preferring and ‐nonpreferring rats , 2003, Proteomics.